1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Spain Pharmaceuticals and Healthcare Report Q4 2016

Spain Pharmaceuticals and Healthcare Report Q4 2016

  • October 2016
  • -
  • Business Monitor International
  • -
  • 82 pages

Includes 3 FREE quarterly updates

BMI View:

Although the Spanish economy is expected to continue outperforming its eurozone counterparts in the coming years, growth in the country's pharmaceutical sector will remain modest. An aging population will ensure the demand for high-value medicines remains high over the long-term. However, rising healthcare costs will see the government continue its pro-generic stance as well as implementing price control measures on medicines, limiting revenue earning opportunities for innovative drugmakers.


Headline Expenditure Projections

- Pharmaceuticals: EUR25.21bn (USD27.96bn) in 2015 to EUR25.70bn (USD27.50bn) in 2016; +2.0% in local currency terms and -1.6% in US dollar terms. Forecast revised upwards from last quarter.

- Healthcare: EUR93.98bn (USD104.23bn) in 2015 to EUR94.59bn (USD101.21bn) in 2016; +0.7% in local currency terms and -2.9% in US dollar terms. Forecast revised downwards from last quarter.

Table Of Contents

Spain Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Spain 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Spain 2012-2020) 13
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Spain 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Spain 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Spain 2012-2020) 18
Prescription Drug Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Spain 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Spain 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Spain 2012-2020) 25
OTC Medicine Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Spain 2012-2020) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Spain 2014-2020) 29
Table: Pharmaceutical Trade Data And Forecasts Local Currency (Spain 2014-2020) 29
Pharmaceuticals and Healthcare Risk/Reward Index 30
Western Europe Risk/Reward Index 30
Spain Risk/Reward Index 36
Rewards 36
Risks 36
Regulatory Review 38
Intellectual Property Issues 39
Parallel Trade 40
OTC Medicines 41
Generic Medicines 42
Pricing Regime 42
Reference Pricing System 44
Reimbursement Regime 46
Market Overview 47
Healthcare Sector 48
Table: Regional Public Hospital Debt - Values In EURmn 49
Table: Healthcare Resources (Spain 2010-2015) 51
Spain Pharmaceuticals and Healthcare Report Q4 2016$$
Table: Healthcare Personnel (Spain 2010-2015) 51
Table: Healthcare Activity (Spain 2010-2015) 52
Research and Development 52
Clinical Trials 53
Epidemiology 55
Competitive Landscape 57
Research Based Industry 57
Table: Multinational Market Activity 58
Generic Drugmakers 59
Biotechnology Sector 61
Pharmaceutical Retail 63
Company Profile 65
Almirall 65
Esteve 68
Demographic Forecast 71
Demographic Outlook 71
Table: Population Headline Indicators (Spain 1990-2025) 72
Table: Key Population Ratios (Spain 1990-2025) 72
Table: Urban/Rural Population and Life Expectancy (Spain 1990-2025) 73
Table: Population By Age Group (Spain 1990-2025) 73
Table: Population By Age Group % (Spain 1990-2025) 74
Glossary 76
Methodology 78
Pharmaceutical Expenditure Forecast Model 78
Healthcare Expenditure Forecast Model 78
Notes On Methodology 79
Risk/Reward Index Methodology 80
Index Overview 81
Table: Pharmaceutical Risk/Reward Index Indicators 81
Indicator Weightings 82

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.